Associated Papers
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine.
Bhagwat SV et al.
Molecular Cancer Therapeutics, 2020
31744895 (PubMed )
Supplement: 15357163mct190183-sup-217635_2_supp_5837227_pzf77z.xlsx › Detailed.Cellline.Mutation.CNA
Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.
Hudson AM et al.
Cancer Research, 2014
Select a paper to view details